Literature DB >> 8611582

Identification of glutamic acid 381 as a candidate active site residue of Pseudomonas aeruginosa exoenzyme S.

S Liu1, S M Kulich, J T Barbieri.   

Abstract

Exoenzyme S of Pseudomonas aeruginosa (ExoS) is a member of the family of bacterial ADP-ribosylating exotoxins (bAREs). Site-directed mutagenesis of glutamic acids within the catalytic domain of ExoS (termed delta N222) allowed the identification of the preferential inactivation of ADP-ribosyltransferase activity by alanine substitution of E381. The specific activity of E381A mutant was 0.02% of wild-type delta N222. Delta N222(E381A) retained the requirement of factor activating exoenzyme S (FAS) activation for the expression of ADP-ribosyltransferase activity. In contrast, E387A, E399A, and E414A mutants possessed ADP-ribosyltransferase activity similar to that of wild-type delta N222. Kinetic evaluation of E381A and two other mutants, E381D and E381S, showed that their primary defect was a lower kcat in the ADP-ribosylation of soybean trypsin inhibitor (SBTI). The Km for NAD and SBTI and activation by FAS varied 2- and 10-fold relative to delta N222. In addition, the E381 mutants possessed identical protease patterns during thrombin and trypsin digestion as delta N222, which indicated that E381 mutants had retained their overall conformation. Together, these data identify E381 as contributing to the catalytic activity of exoenzyme S.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611582     DOI: 10.1021/bi952340g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras.

Authors:  M L Henriksson; R Rosqvist; M Telepnev; H Wolf-Watz; B Hallberg
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

2.  Characterization of the enzymatic component of Clostridium perfringens iota-toxin.

Authors:  M Nagahama; Y Sakaguchi; K Kobayashi; S Ochi; J Sakurai
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

3.  Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells.

Authors:  A J Vallis; V Finck-Barbançon; T L Yahr; D W Frank
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Pseudomonas aeruginosa exoenzyme S is a biglutamic acid ADP-ribosyltransferase.

Authors:  J Radke; K J Pederson; J T Barbieri
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

5.  14-3-3 proteins are required for the inhibition of Ras by exoenzyme S.

Authors:  M L Henriksson; U Trollér; B Hallberg
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

6.  Phosphorylation-independent interaction between 14-3-3 and exoenzyme S: from structure to pathogenesis.

Authors:  Christian Ottmann; Lubna Yasmin; Michael Weyand; Jeffrey L Veesenmeyer; Maureen H Diaz; Ruth H Palmer; Matthew S Francis; Alan R Hauser; Alfred Wittinghofer; Bengt Hallberg
Journal:  EMBO J       Date:  2007-01-18       Impact factor: 11.598

7.  Biochemical relationships between the 53-kilodalton (Exo53) and 49-kilodalton (ExoS) forms of exoenzyme S of Pseudomonas aeruginosa.

Authors:  S Liu; T L Yahr; D W Frank; J T Barbieri
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

8.  The ADP-ribosylation domain of Pseudomonas aeruginosa ExoS is required for membrane bleb niche formation and bacterial survival within epithelial cells.

Authors:  Annette A Angus; David J Evans; Joseph T Barbieri; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2010-08-23       Impact factor: 3.441

9.  Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages.

Authors:  Claudia L Rocha; Jenifer Coburn; Elizabeth A Rucks; Joan C Olson
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

10.  Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo.

Authors:  Maria L Henriksson; Charlotta Sundin; Anna L Jansson; Ake Forsberg; Ruth H Palmer; Bengt Hallberg
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.